R0043/2026-03-28/Q002/S02
WebSearch — FDA and DoD regulatory guidance addressing automation bias
Summary
| Field |
Value |
| Source/Database |
WebSearch (two queries) |
| Query terms |
(1) FDA guidance AI clinical decision support "automation bias" "overreliance" requirements 2024 2025; (2) DOD AI ethical principles "responsible AI" requirements procurement specifications trustworthy 2024 2025 |
| Filters |
None |
| Results returned |
20 |
| Results selected |
3 |
| Results rejected |
17 |
Selected Results
| Result |
Title |
URL |
Rationale |
| S02-R01 |
FDA CDS Guidance (Cooley analysis) |
https://www.cooley.com/news/insight/2026/2026-01-20-automation-bias-and-clinical-practice-fda-makes-incremental-updates-to-clinical-decision-support-software-guidance |
FDA's explicit use of "automation bias" in CDS guidance |
| S02-R02 |
DoD Responsible AI Guidelines (DIU) |
https://www.diu.mil/responsible-ai-guidelines |
DoD procurement requirements including RAI tenets |
| S02-R03 |
FSSCC AI Risk Management Framework |
https://www.lowenstein.com/news-insights/publications/client-alerts/financial-services-ai-risk-management-framework-operationalizing-the-230-control-objectives-before-the-market-wakes-up-data-privacy |
Financial services 230 control objectives |
Rejected Results
| Result |
Title |
URL |
Rationale |
| S02-R04 |
Various FDA and DoD general guidance |
Multiple |
17 results rejected: general AI regulation overviews; compliance guides without specific anti-sycophancy requirements; commercial AI tools |
Notes
The FDA CDS guidance is the strongest evidence of regulatory requirements directly naming "automation bias." The DoD RAI principles address trustworthiness generally. Financial services has the most control objectives (230) but none specifically targeting AI agreeableness.